The key change is increased permeability of the vascular endothelium. Inflammatory mediators loosen the barrier that normally limits movement from vessels into a body cavity. As leakage increases, fluid can carry proteins and immune cells; in some cases, malignant cells also enter. This composition helps connect the effusion to an inflammatory, infectious, malignant, or injury-related process.
Light’s criteria use relative measurements rather than fluid appearance alone. Clinicians compare protein and lactate dehydrogenase levels in pleural fluid with corresponding serum levels. These paired biochemical results help classify the effusion as exudative or transudative, providing an initial framework for deciding whether inflammation, infection, malignancy, or another process requires further investigation.
Different conditions can disrupt vascular permeability through distinct forms of tissue disturbance. Inflammation and infection promote leakage through inflammatory signaling, while malignancy or tissue injury can also impair the vascular barrier. Because these processes may produce protein-rich fluid with overlapping features, classification alone does not identify the disease; additional cellular, microbiological, cytological, and biochemical information is needed.
The cellular content can provide clues about the process affecting the pleural space. Immune cells are consistent with an inflammatory or infectious response, whereas malignant cells may indicate involvement by cancer. Cell counts and cytology therefore add information beyond protein and lactate dehydrogenase measurements, helping clinicians connect the fluid findings with a possible underlying disease.
Evaluation can combine cell counts, microbiology, cytology, and biochemical testing. Biochemical measurements support classification with Light’s criteria, microbiology examines the possibility of infection, and cytology assesses whether malignant cells are present. Cell counts describe the cellular component. Together, these analyses provide complementary evidence rather than relying on a single laboratory result.
Pleural-fluid measurements are interpreted alongside serum measurements, particularly for protein and lactate dehydrogenase. This paired approach forms the basis of Light’s criteria and helps distinguish exudative from transudative fluid. Comparing the two sources is important because the classification depends on their relationship, not simply on an isolated pleural-fluid value.
The fluid finding is an indicator that requires investigation of the underlying disease. Results from biochemical testing, cell counts, microbiology, and cytology can narrow the possibilities by revealing inflammatory, infectious, or malignant features. Establishing that cause has direct clinical relevance because the combined findings guide treatment rather than treating the fluid classification as the final diagnosis.
In the pleural space, inflammatory mediators can increase endothelial leakage and allow proteins, immune cells, and sometimes malignant cells to accumulate in the fluid. This makes pleural-fluid analysis useful for linking local findings with systemic disease processes. Applying Light’s criteria together with laboratory testing helps clinicians classify the effusion and investigate its cause.